Barbara Costa Selected Research

arachidonoylserotonin

10/2013	Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.
6/2010	The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara Costa Research Topics

Disease

17	Neoplasms (Cancer) 06/2022 - 08/2004
15	Hyperalgesia 01/2015 - 01/2002
14	Glioma (Gliomas) 01/2021 - 03/2004
13	Inflammation (Inflammations) 01/2022 - 01/2002
13	Neuralgia (Stump Neuralgia) 06/2015 - 07/2005
12	Pain (Aches) 01/2015 - 07/2005
8	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2013
6	Neuroinflammatory Diseases 01/2022 - 01/2014
5	Separation Anxiety (Separation Anxiety Disorder) 01/2018 - 04/2009
5	Carcinogenesis 11/2010 - 08/2003
4	Chronic Pain 01/2015 - 07/2005
3	Necrosis 11/2018 - 08/2006
3	Central Nervous System Cavernous Hemangioma 08/2012 - 09/2009
2	Demyelinating Diseases (Demyelinating Disease) 03/2022 - 07/2005
2	Nervous System Diseases (Neurological Disorders) 01/2019 - 11/2003
2	Anxiety Disorders (Anxiety Disorder) 01/2016 - 01/2012
2	Melanoma (Melanoma, Malignant) 08/2015 - 07/2015
2	Edema (Dropsy) 05/2012 - 03/2004
2	Depressive Disorder (Melancholia) 05/2011 - 11/2009
2	Hypoxia (Hypoxemia) 11/2010 - 08/2010
2	Hyperglycemia 07/2010 - 12/2009
2	Carcinoma (Carcinomatosis) 08/2004 - 08/2003
1	Triple Negative Breast Neoplasms 06/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 03/2022
1	Chronic Progressive Multiple Sclerosis 03/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 12/2021
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Pathologic Processes 03/2017
1	Neoplasm Metastasis (Metastasis) 03/2017
1	Heart Diseases (Heart Disease) 01/2017

Drug/Important Bio-Agent (IBA)

21	LigandsIBA 03/2022 - 08/2003
20	Proteins (Proteins, Gene)FDA Link 03/2022 - 02/2008
9	CannabinoidsIBA 08/2015 - 01/2002
9	CarrageenanIBA 10/2013 - 01/2002
7	palmidrolIBA 06/2015 - 01/2002
5	Pharmaceutical PreparationsIBA 03/2015 - 01/2002
4	CannabidiolIBA 06/2022 - 03/2004
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2017 - 10/2002
4	CytokinesIBA 01/2017 - 08/2006
4	NeurosteroidsIBA 06/2016 - 05/2011
4	SteroidsIBA 01/2016 - 03/2004
4	Nerve Growth Factor (NGF)IBA 01/2015 - 12/2009
4	PK 11195 (PK11195)IBA 01/2010 - 07/2004
4	GABA-A Receptors (GABA(A) Receptor)IBA 02/2008 - 07/2004
3	Biological ProductsIBA 01/2022 - 07/2011
3	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2010
3	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 08/2015 - 07/2005
3	Fatty Acids (Saturated Fatty Acids)IBA 04/2014 - 10/2002
3	AmidesIBA 04/2014 - 10/2002
3	EndocannabinoidsIBA 12/2013 - 01/2002
3	Formaldehyde (Formol)FDA Link 10/2013 - 06/2010
3	Phosphotransferases (Kinase)IBA 08/2012 - 08/2003
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2010 - 08/2003
3	Cannabinoid Receptors (Cannabinoid Receptor)IBA 08/2006 - 07/2005
3	Indomethacin (Indometacin)FDA LinkGeneric 10/2005 - 01/2002
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2019 - 01/2018
2	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2018 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 08/2015 - 07/2015
2	Streptozocin (Streptozotocin)FDA Link 01/2015 - 12/2009
2	Capsaicin (Zostrix)FDA Link 04/2014 - 09/2012
2	LipopolysaccharidesIBA 01/2014 - 05/2012
2	arachidonoylserotoninIBA 10/2013 - 06/2010
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 08/2012 - 08/2004
2	EnzymesIBA 07/2011 - 11/2010
2	Fumarate Hydratase (Fumarase)IBA 11/2010 - 08/2010
2	RimonabantIBA 07/2010 - 07/2005
2	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 06/2010 - 10/2005
2	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 06/2010 - 10/2005
2	PregnenoloneIBA 12/2009 - 05/2008
2	Oxytocin (Pitocin)FDA LinkGeneric 11/2009 - 07/2009
2	Analgesics (Analgesic Drugs)IBA 10/2008 - 09/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2007 - 08/2006
1	Insulin-Like Growth Factor I (IGF-1)IBA 06/2022
1	Myelin Basic ProteinIBA 03/2022
1	Myelin-Oligodendrocyte GlycoproteinIBA 03/2022
1	Coffee FDA Link 01/2022
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2020
1	ChromatinIBA 12/2020
1	Glycoproteins (Glycoprotein)IBA 01/2019
1	Inflammation MediatorsIBA 11/2018
1	compound 106IBA 01/2018
1	Biological FactorsIBA 01/2018
1	jasplakinolideIBA 01/2018
1	SynucleinsIBA 01/2018
1	IntegrinsIBA 01/2018
1	Glucagon-Like Peptide-1 ReceptorIBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 01/2017
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 01/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2017
1	GTP-Binding Proteins (G-Protein)IBA 01/2017
1	Excitatory Amino AcidsIBA 01/2017
1	CurcuminIBA 01/2017
1	crocinIBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2017

Therapy/Procedure

9	Therapeutics 12/2021 - 01/2006
3	Transplantation 01/2021 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2019 - 08/2015
1	Injections 01/2019